Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Peter Kabos

Concepts (401)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
52
2025
2133
5.830
 Why?
Receptors, Estrogen
21
2025
422
3.080
 Why?
Receptor, ErbB-2
14
2024
326
2.000
 Why?
Receptors, Progesterone
11
2020
341
1.250
 Why?
Brain Neoplasms
14
2023
1145
1.000
 Why?
Keratin-5
6
2022
50
0.840
 Why?
Estrogens
7
2023
347
0.820
 Why?
Triple Negative Breast Neoplasms
6
2023
193
0.810
 Why?
Breast Neoplasms, Male
3
2018
29
0.780
 Why?
Biomarkers, Tumor
7
2022
1164
0.780
 Why?
Stem Cells
8
2006
575
0.770
 Why?
Antineoplastic Agents, Hormonal
7
2025
155
0.720
 Why?
Tetrahydronaphthalenes
1
2021
30
0.710
 Why?
Estrogen Receptor alpha
4
2024
130
0.700
 Why?
Drug Resistance, Neoplasm
5
2025
752
0.700
 Why?
Neoplasm Metastasis
4
2020
611
0.690
 Why?
Immunoprecipitation
4
2020
157
0.680
 Why?
Neoplastic Cells, Circulating
1
2020
70
0.660
 Why?
Benzodiazepines
1
2021
134
0.660
 Why?
Radiosurgery
3
2023
321
0.650
 Why?
Brain Edema
2
2023
60
0.650
 Why?
Neurons
8
2004
1494
0.640
 Why?
Carcinoma, Intraductal, Noninfiltrating
2
2017
55
0.610
 Why?
Epithelial-Mesenchymal Transition
1
2020
201
0.600
 Why?
Leukocytes, Mononuclear
2
2020
546
0.590
 Why?
Gene Expression Regulation, Neoplastic
11
2025
1336
0.570
 Why?
Gene Expression Profiling
7
2020
1687
0.570
 Why?
Fanconi Anemia Complementation Group N Protein
1
2017
5
0.550
 Why?
Polyadenylation
1
2017
40
0.540
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2024
1560
0.540
 Why?
High-Throughput Nucleotide Sequencing
4
2019
487
0.540
 Why?
Neoplastic Stem Cells
7
2020
378
0.540
 Why?
Female
54
2025
68734
0.540
 Why?
Organoplatinum Compounds
1
2016
41
0.530
 Why?
Carcinogenesis
2
2020
213
0.530
 Why?
Cancer-Associated Fibroblasts
1
2016
13
0.530
 Why?
Fluorouracil
1
2016
197
0.490
 Why?
Artifacts
1
2016
126
0.490
 Why?
CD146 Antigen
3
2021
41
0.480
 Why?
Mitochondrial Proteins
1
2017
247
0.470
 Why?
Thrombocytopenia
1
2016
186
0.460
 Why?
MCF-7 Cells
4
2020
114
0.460
 Why?
Maytansine
1
2014
16
0.450
 Why?
Cell Line, Tumor
15
2025
3186
0.440
 Why?
Humans
67
2025
129625
0.440
 Why?
Trastuzumab
5
2023
100
0.410
 Why?
Analgesics, Opioid
1
2021
913
0.410
 Why?
Binding Sites
1
2016
1248
0.400
 Why?
RNA-Binding Proteins
1
2016
387
0.400
 Why?
Tumor Microenvironment
4
2021
627
0.390
 Why?
Receptors, Cytoplasmic and Nuclear
1
2014
217
0.390
 Why?
Neoplasms, Hormone-Dependent
1
2012
38
0.390
 Why?
Antineoplastic Agents
4
2023
2046
0.390
 Why?
Tamoxifen
5
2025
197
0.390
 Why?
Homeodomain Proteins
5
2018
494
0.380
 Why?
Piperazines
2
2024
340
0.370
 Why?
MicroRNAs
5
2016
679
0.370
 Why?
Neoplasm Recurrence, Local
5
2021
958
0.370
 Why?
Chemotherapy, Adjuvant
5
2023
377
0.360
 Why?
Protein Kinase Inhibitors
5
2021
887
0.360
 Why?
RNA
2
2016
882
0.360
 Why?
Estradiol
3
2015
494
0.350
 Why?
Neoadjuvant Therapy
3
2021
379
0.350
 Why?
Mutation
3
2021
3717
0.350
 Why?
Antibodies, Monoclonal, Humanized
2
2021
757
0.340
 Why?
Pyridines
2
2024
478
0.340
 Why?
Liver Neoplasms
1
2015
639
0.340
 Why?
Progestins
5
2020
78
0.330
 Why?
Pyrimidines
3
2018
459
0.320
 Why?
Colorectal Neoplasms
1
2016
749
0.310
 Why?
Tumor Cells, Cultured
7
2020
943
0.310
 Why?
Prognosis
7
2021
3774
0.310
 Why?
Carcinoma, Ductal, Breast
2
2020
80
0.300
 Why?
Hydrocephalus
3
2023
103
0.300
 Why?
Adenocarcinoma
1
2015
893
0.300
 Why?
Bone Marrow Cells
2
2014
302
0.290
 Why?
Signal Transduction
5
2018
4931
0.280
 Why?
Middle Aged
16
2024
31136
0.280
 Why?
Neoplasm Staging
4
2021
1282
0.260
 Why?
Astrocytes
5
2023
195
0.260
 Why?
Helix-Loop-Helix Motifs
2
2002
12
0.250
 Why?
Necrosis
2
2019
232
0.250
 Why?
Cluster Analysis
4
2019
482
0.250
 Why?
Chondroitin Sulfate Proteoglycans
2
2006
10
0.240
 Why?
Sequence Analysis, RNA
2
2019
427
0.240
 Why?
Fatty Acid Synthase, Type I
1
2025
11
0.240
 Why?
Neuroglia
2
2003
163
0.240
 Why?
Aged
14
2024
22061
0.230
 Why?
Neoplasm Grading
2
2017
282
0.230
 Why?
Genetic Therapy
2
2003
289
0.230
 Why?
Mice, Inbred NOD
5
2021
587
0.220
 Why?
Aromatase Inhibitors
2
2021
51
0.220
 Why?
Disease-Free Survival
4
2024
646
0.220
 Why?
Carbolines
1
2024
30
0.220
 Why?
Triazines
1
2024
38
0.220
 Why?
Adult
16
2024
35599
0.220
 Why?
Animals
27
2021
35391
0.210
 Why?
Progesterone
3
2014
245
0.210
 Why?
Morpholines
1
2024
122
0.210
 Why?
Extracellular Matrix Proteins
1
2004
144
0.210
 Why?
Glioma
5
2006
348
0.200
 Why?
Mice
19
2021
16961
0.200
 Why?
Keratin-17
1
2022
4
0.200
 Why?
Aquaporin 4
2
2023
95
0.200
 Why?
Nerve Regeneration
1
2002
62
0.200
 Why?
Stromal Cells
2
2020
106
0.200
 Why?
Triglycerides
1
2025
528
0.200
 Why?
Mice, SCID
4
2020
350
0.200
 Why?
Tumor Suppressor Proteins
2
2015
314
0.200
 Why?
Immunoconjugates
1
2023
104
0.190
 Why?
Down-Regulation
4
2015
636
0.190
 Why?
Cell-Free Nucleic Acids
1
2022
32
0.190
 Why?
Neoplasm Invasiveness
3
2020
481
0.190
 Why?
Medicare
3
2023
708
0.190
 Why?
Interleukin-13 Receptor alpha2 Subunit
1
2021
5
0.190
 Why?
Lipid Metabolism
1
2025
503
0.190
 Why?
Cyclins
1
2002
89
0.190
 Why?
Aged, 80 and over
4
2024
7052
0.180
 Why?
Tumor Suppressor Protein p53
2
2015
507
0.180
 Why?
Gene Regulatory Networks
2
2014
281
0.180
 Why?
Insulin Receptor Substrate Proteins
1
2020
59
0.180
 Why?
gamma-Aminobutyric Acid
1
2002
168
0.170
 Why?
Cell Adhesion Molecules
1
2021
173
0.170
 Why?
RNA, Messenger
3
2019
2708
0.170
 Why?
Cancer Care Facilities
1
2020
32
0.170
 Why?
Meningeal Carcinomatosis
1
2020
8
0.170
 Why?
Hyaluronan Receptors
4
2014
97
0.170
 Why?
SEER Program
1
2021
202
0.170
 Why?
Transcriptome
2
2019
876
0.160
 Why?
Antineoplastic Agents, Immunological
2
2019
181
0.160
 Why?
Carcinoma, Lobular
1
2020
47
0.160
 Why?
Cell Proliferation
6
2025
2373
0.160
 Why?
Gene Library
2
2019
115
0.160
 Why?
Aminopyridines
1
2020
98
0.160
 Why?
Collagen
2
2020
435
0.160
 Why?
Repressor Proteins
1
2002
406
0.160
 Why?
Retrospective Studies
5
2023
14522
0.160
 Why?
Lymphatic Metastasis
2
2017
320
0.160
 Why?
Benzimidazoles
1
2020
162
0.160
 Why?
Antigens, Neoplasm
1
2021
308
0.160
 Why?
ErbB Receptors
2
2020
607
0.150
 Why?
Paclitaxel
1
2020
217
0.150
 Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
51
0.150
 Why?
beta Catenin
1
2020
225
0.140
 Why?
Xenograft Model Antitumor Assays
4
2017
808
0.140
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2017
81
0.140
 Why?
Treatment Outcome
5
2023
10219
0.140
 Why?
Heterografts
4
2020
133
0.140
 Why?
RNA Polymerase III
1
2017
26
0.140
 Why?
Disease Progression
4
2018
2627
0.140
 Why?
3' Untranslated Regions
1
2017
138
0.130
 Why?
Pyrroles
1
2017
202
0.130
 Why?
Neoplasms, Radiation-Induced
1
2016
71
0.130
 Why?
Genital Neoplasms, Female
1
2017
82
0.130
 Why?
Single-Cell Analysis
1
2019
274
0.130
 Why?
Receptors, Androgen
1
2017
143
0.130
 Why?
Gene Expression
2
2016
1465
0.120
 Why?
Ovary
1
2017
209
0.120
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
949
0.120
 Why?
Neoplasms, Second Primary
1
2016
106
0.120
 Why?
Combined Modality Therapy
2
2019
1203
0.120
 Why?
Ribosomal Proteins
1
2015
77
0.120
 Why?
Paracrine Communication
1
2015
61
0.120
 Why?
Proto-Oncogene Proteins c-akt
1
2017
432
0.120
 Why?
DNA Primers
1
2016
511
0.120
 Why?
Pyrazoles
1
2018
404
0.120
 Why?
Risk Reduction Behavior
1
2016
209
0.120
 Why?
Hodgkin Disease
1
2016
134
0.120
 Why?
Fibroblasts
1
2020
953
0.120
 Why?
Obesity
2
2018
2882
0.110
 Why?
Reactive Oxygen Species
1
2017
593
0.110
 Why?
Azepines
1
2015
88
0.110
 Why?
STAT5 Transcription Factor
1
2014
48
0.110
 Why?
Peptides
1
2020
926
0.110
 Why?
Clinical Decision-Making
1
2017
301
0.110
 Why?
Odds Ratio
1
2017
1019
0.110
 Why?
Receptors, Steroid
1
2014
49
0.110
 Why?
Apoptosis
4
2017
2492
0.110
 Why?
Opioid-Related Disorders
1
2021
483
0.100
 Why?
Sensitivity and Specificity
2
2016
1843
0.100
 Why?
DNA-Binding Proteins
2
2015
1445
0.100
 Why?
Disease Models, Animal
4
2017
4078
0.100
 Why?
CD24 Antigen
1
2012
20
0.100
 Why?
RNA Interference
1
2014
450
0.100
 Why?
Retinoids
1
2012
33
0.100
 Why?
Cell Differentiation
4
2004
1891
0.100
 Why?
Anthracyclines
2
2023
49
0.100
 Why?
Clinical Trials as Topic
1
2017
1005
0.100
 Why?
Comorbidity
1
2017
1547
0.100
 Why?
Taxoids
2
2023
98
0.100
 Why?
Male
8
2018
63670
0.100
 Why?
United States
4
2023
13871
0.090
 Why?
Doxorubicin
3
2022
329
0.090
 Why?
Genome, Human
1
2014
394
0.090
 Why?
Small Molecule Libraries
1
2012
86
0.090
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2012
169
0.090
 Why?
Drug Discovery
1
2012
130
0.090
 Why?
Tumor Burden
1
2012
286
0.090
 Why?
Mitochondria
1
2017
876
0.090
 Why?
Rats
5
2017
5483
0.090
 Why?
Logistic Models
1
2016
1986
0.090
 Why?
Basic Helix-Loop-Helix Transcription Factors
2
2002
235
0.090
 Why?
Time Factors
3
2020
6555
0.080
 Why?
Lung Neoplasms
1
2023
2342
0.080
 Why?
Nuclear Proteins
1
2015
660
0.080
 Why?
Oligonucleotide Array Sequence Analysis
1
2012
756
0.080
 Why?
Dendritic Cells
2
2004
481
0.080
 Why?
Estrogen Antagonists
1
2010
46
0.080
 Why?
Protein Binding
1
2016
2124
0.080
 Why?
Transforming Growth Factor beta
1
2012
460
0.080
 Why?
Cell Culture Techniques
2
2020
338
0.080
 Why?
BRCA2 Protein
1
2009
54
0.080
 Why?
Administration, Oral
2
2024
787
0.080
 Why?
Pregnancy Complications, Neoplastic
1
2009
53
0.080
 Why?
Thrombophilia
1
2009
81
0.080
 Why?
Receptors, CXCR4
2
2006
83
0.080
 Why?
Quinolines
2
2021
156
0.070
 Why?
Practice Patterns, Physicians'
1
2017
1271
0.070
 Why?
Cell Movement
3
2015
948
0.070
 Why?
Cells, Cultured
3
2006
4084
0.070
 Why?
Brain
2
2023
2673
0.070
 Why?
Stem Cell Transplantation
3
2004
164
0.070
 Why?
Tumor Necrosis Factor-alpha
2
2002
1202
0.070
 Why?
Genetic Predisposition to Disease
1
2016
2274
0.070
 Why?
Proteoglycans
2
2006
109
0.070
 Why?
Rats, Sprague-Dawley
2
2002
2395
0.070
 Why?
Radiotherapy, Adjuvant
2
2018
208
0.070
 Why?
Risk Factors
2
2020
9786
0.070
 Why?
Drug Delivery Systems
1
2010
333
0.070
 Why?
Immunohistochemistry
2
2017
1685
0.070
 Why?
Aurora Kinase A
2
2018
54
0.070
 Why?
Severity of Illness Index
1
2014
2739
0.060
 Why?
Biopsy
2
2020
1088
0.060
 Why?
Nervous System
1
2006
67
0.060
 Why?
Tomography, X-Ray Computed
1
2015
2512
0.060
 Why?
Rats, Inbred F344
2
2003
259
0.060
 Why?
Mass Spectrometry
2
2020
714
0.060
 Why?
Neoplasm Transplantation
2
2016
256
0.060
 Why?
Infant, Premature, Diseases
1
2006
93
0.060
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 5
1
2004
1
0.060
 Why?
Aggrecans
1
2004
14
0.060
 Why?
Isoquinolines
1
2024
41
0.060
 Why?
Lectins, C-Type
1
2004
71
0.060
 Why?
Azetidines
1
2024
40
0.060
 Why?
Cyclophosphamide
2
2018
234
0.050
 Why?
Maximum Tolerated Dose
1
2024
193
0.050
 Why?
Adipose Tissue
2
2018
591
0.050
 Why?
Cell Line
2
2014
2784
0.050
 Why?
Hemangioma, Cavernous, Central Nervous System
1
2003
6
0.050
 Why?
Mastectomy, Segmental
2
2017
86
0.050
 Why?
Glioblastoma
2
2006
322
0.050
 Why?
Aromatase
1
2023
31
0.050
 Why?
Inhibitor of Differentiation Protein 1
1
2002
6
0.050
 Why?
Inhibitor of Differentiation Protein 2
1
2002
5
0.050
 Why?
Mice, Inbred C57BL
5
2004
5455
0.050
 Why?
Camptothecin
1
2023
110
0.050
 Why?
Neoplasms, Multiple Primary
1
2003
55
0.050
 Why?
Edema
1
2023
124
0.050
 Why?
Pyramidal Tracts
1
2002
26
0.050
 Why?
Neurites
1
2002
45
0.050
 Why?
Hepatocyte Nuclear Factor 3-alpha
1
2022
8
0.050
 Why?
Sciatic Nerve
1
2002
56
0.050
 Why?
Gonadotropin-Releasing Hormone
1
2024
205
0.050
 Why?
Vimentin
1
2022
50
0.050
 Why?
Transcription Factor HES-1
1
2002
5
0.050
 Why?
Interleukin-12
1
2002
118
0.050
 Why?
Phenotype
1
2010
3075
0.050
 Why?
Frontal Lobe
1
2002
154
0.050
 Why?
Blotting, Western
1
2004
1206
0.050
 Why?
Oligonucleotides, Antisense
1
2002
113
0.050
 Why?
Fibroblast Growth Factors
1
2002
169
0.050
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2002
117
0.050
 Why?
Mice, Inbred BALB C
1
2004
1250
0.050
 Why?
Ependymoma
1
2003
161
0.050
 Why?
Neoplasms
1
2015
2455
0.040
 Why?
TOR Serine-Threonine Kinases
1
2024
398
0.040
 Why?
Protein-Lysine 6-Oxidase
1
2020
8
0.040
 Why?
Cerebral Cortex
1
2004
439
0.040
 Why?
Nucleosomes
1
2022
137
0.040
 Why?
Clinical Trials, Phase I as Topic
1
2020
51
0.040
 Why?
Hospitals, University
1
2021
178
0.040
 Why?
Nervous System Diseases
1
2003
251
0.040
 Why?
Animals, Newborn
1
2002
835
0.040
 Why?
Membrane Glycoproteins
1
2002
477
0.040
 Why?
Adherens Junctions
1
2020
25
0.040
 Why?
Dose-Response Relationship, Drug
1
2024
2011
0.040
 Why?
Gene Knockout Techniques
1
2020
109
0.040
 Why?
Protein Interaction Mapping
1
2020
108
0.040
 Why?
Kaplan-Meier Estimate
1
2021
851
0.040
 Why?
Interferon-gamma
1
2002
772
0.040
 Why?
Mice, Nude
2
2015
682
0.040
 Why?
DNA, Complementary
1
2019
270
0.040
 Why?
beta-Galactosidase
3
2002
77
0.040
 Why?
Loss of Function Mutation
1
2018
39
0.040
 Why?
Immunotherapy
1
2003
596
0.040
 Why?
Maintenance Chemotherapy
1
2018
22
0.040
 Why?
Cadherins
1
2020
190
0.040
 Why?
Wnt Signaling Pathway
1
2020
170
0.040
 Why?
Nausea
1
2018
111
0.040
 Why?
Promoter Regions, Genetic
2
2012
1207
0.040
 Why?
Breast
1
2018
153
0.030
 Why?
Phenylthiohydantoin
1
2017
41
0.030
 Why?
Mastectomy
1
2018
132
0.030
 Why?
Diarrhea
1
2018
182
0.030
 Why?
Antigens, CD
1
2020
487
0.030
 Why?
Mammary Neoplasms, Experimental
1
2017
66
0.030
 Why?
Area Under Curve
1
2017
304
0.030
 Why?
Ovariectomy
1
2017
135
0.030
 Why?
Steroids
1
2017
158
0.030
 Why?
Benzamides
1
2017
203
0.030
 Why?
Nitriles
1
2017
170
0.030
 Why?
Fatigue
1
2018
318
0.030
 Why?
Cell Membrane
1
2020
734
0.030
 Why?
Flow Cytometry
2
2012
1159
0.030
 Why?
Apoptosis Regulatory Proteins
2
2009
182
0.030
 Why?
Proto-Oncogene Proteins c-mdm2
1
2015
64
0.030
 Why?
Chromatography, Liquid
1
2017
423
0.030
 Why?
Tumor Protein p73
1
2015
14
0.030
 Why?
Postmenopause
1
2017
349
0.030
 Why?
Transcription Factors
1
2002
1647
0.030
 Why?
Weight Gain
1
2018
509
0.030
 Why?
Molecular Targeted Therapy
1
2017
391
0.030
 Why?
Gene Knockdown Techniques
1
2015
317
0.030
 Why?
Serrate-Jagged Proteins
1
2014
27
0.030
 Why?
Jagged-1 Protein
1
2014
23
0.030
 Why?
Argonaute Proteins
1
2014
27
0.030
 Why?
Wnt-5a Protein
1
2014
21
0.030
 Why?
Software
1
2019
608
0.030
 Why?
Matrix Metalloproteinase 2
1
2014
54
0.030
 Why?
Testosterone
1
2017
372
0.030
 Why?
Transcription, Genetic
1
2020
1418
0.030
 Why?
Interleukin-6
1
2017
723
0.030
 Why?
Cellular Microenvironment
1
2014
83
0.030
 Why?
Cell Transformation, Neoplastic
1
2015
326
0.030
 Why?
Wnt Proteins
1
2014
127
0.030
 Why?
Guideline Adherence
1
2017
527
0.030
 Why?
Gene Expression Regulation
1
2022
2542
0.030
 Why?
Socioeconomic Factors
1
2017
1213
0.030
 Why?
Acitretin
1
2012
3
0.020
 Why?
Miconazole
1
2012
5
0.020
 Why?
Calcium-Binding Proteins
1
2014
213
0.020
 Why?
Isotretinoin
1
2012
23
0.020
 Why?
Intercellular Signaling Peptides and Proteins
1
2014
374
0.020
 Why?
Luciferases
1
2012
147
0.020
 Why?
Genes, Reporter
1
2012
265
0.020
 Why?
Biomarkers
2
2017
3968
0.020
 Why?
Tretinoin
1
2012
130
0.020
 Why?
Magnetic Resonance Imaging
2
2019
3394
0.020
 Why?
Vascular Endothelial Growth Factor A
1
2014
530
0.020
 Why?
Risk Assessment
1
2020
3262
0.020
 Why?
Green Fluorescent Proteins
1
2012
388
0.020
 Why?
Follow-Up Studies
1
2020
4894
0.020
 Why?
Diet
1
2018
1213
0.020
 Why?
Colorado
1
2020
4404
0.020
 Why?
Proto-Oncogene Proteins
1
2014
636
0.020
 Why?
Base Sequence
1
2014
2147
0.020
 Why?
HEK293 Cells
1
2012
698
0.020
 Why?
Age Factors
1
2017
3152
0.020
 Why?
Practice Guidelines as Topic
1
2017
1501
0.020
 Why?
Pregnancy Trimester, Second
1
2009
77
0.020
 Why?
Molecular Sequence Data
1
2014
2835
0.020
 Why?
Hypertension
1
2018
1243
0.020
 Why?
Pregnancy Trimester, First
1
2009
137
0.020
 Why?
Endothelial Cells
1
2014
749
0.020
 Why?
Lymph Node Excision
1
2009
164
0.020
 Why?
Transplantation, Heterologous
1
2008
192
0.020
 Why?
Membrane Proteins
1
2014
1125
0.020
 Why?
Neoplasms, Experimental
1
2008
170
0.020
 Why?
CD8-Positive T-Lymphocytes
2
2002
855
0.020
 Why?
Infant, Newborn
2
2009
5756
0.020
 Why?
CD4-Positive T-Lymphocytes
2
2002
1058
0.020
 Why?
Chemokines, CXC
1
2006
70
0.020
 Why?
Nestin
1
2006
19
0.020
 Why?
Laminin
1
2006
69
0.020
 Why?
Intermediate Filament Proteins
1
2006
57
0.020
 Why?
Chemokine CXCL12
1
2006
79
0.020
 Why?
Glial Fibrillary Acidic Protein
1
2006
91
0.020
 Why?
Lasers
1
2006
132
0.020
 Why?
Drug Combinations
1
2006
331
0.010
 Why?
Adolescent
1
2024
20412
0.010
 Why?
Culture Media, Conditioned
1
2004
110
0.010
 Why?
RNA, Small Interfering
1
2006
591
0.010
 Why?
Injections, Intralesional
1
2003
33
0.010
 Why?
TNF-Related Apoptosis-Inducing Ligand
1
2002
44
0.010
 Why?
3T3 Cells
1
2002
154
0.010
 Why?
Random Allocation
1
2003
347
0.010
 Why?
Nerve Tissue Proteins
1
2006
569
0.010
 Why?
Models, Neurological
1
2004
242
0.010
 Why?
Adenoviridae
1
2002
193
0.010
 Why?
Infant, Premature
1
2006
542
0.010
 Why?
Reference Values
1
2003
794
0.010
 Why?
Genetic Vectors
1
2002
314
0.010
 Why?
Oligodendroglia
1
2002
167
0.010
 Why?
Transfection
1
2002
915
0.010
 Why?
Recombinant Fusion Proteins
1
2002
651
0.010
 Why?
Survival Rate
1
2003
1872
0.010
 Why?
Case-Control Studies
1
2006
3378
0.010
 Why?
Pregnancy
1
2009
6417
0.010
 Why?
Vaccination
1
2003
1347
0.010
 Why?
Prospective Studies
1
2006
7135
0.010
 Why?
Infant
1
2006
8995
0.010
 Why?
Kabos's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (401) concept(s)
_
Co-Authors Expand Description
See all (69) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)